Workshop 1 - Vaccine Safety

WORKSHOP: Vaccine Safety [OFFSITE]

Pre-congress day workshops are OFFSITE at the Alexandre Hotel Fira Congress

Vaccine Saftey 

09:00 Workshop Leader opening remarks

Dr Walter Straus, VP, Clinical Safety, Moderna

9:10 A case for syndromic surveillance Rebecca Chandler, Clinical Development Vaccine Safety Lead, CEPI

9:40 Post marketing assessment of vaccine attributable risk of both myocarditis and TTS: challenges and future directionsProfessor Kristine Macartney, Director, Australian National Centre for Immunisation Research and Surveillance

10:10 Characterising the clinical risk factors and biomarkers associated with TTS, myocarditis, and pericarditis following COVID-19 vaccinationDr Ofer Levy, Director, Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Professor, Harvard Medical School

10:40 Global Safety Assessment of the Moderna, Inc. COVID-19 Vaccine mRNA-1273 (SPIKEVAX) Following Two Years of UseVeronica Urdaneta, Senior Director, Global Safety Physician, Pharmacovigilance, Moderna

Dr Marco Cavaleri, Head of Biological Health Threats and Vaccines Strategy, EMA

Dame Sarah Gilbert, FRS, Professor of Vaccinology, Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford

Dr Cynthia Rohde, DABT, Drug Safety Research & Development Vaccine Therapeutic Area Lead, PfizerDr Ofer Levy, Director, Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Professor, Harvard Medical School

Hanneke Schuitemaker, Vice President And Head Of Viral Vaccine Discovery And Translational Medicine, Janssen

Veronica Urdaneta, Senior Director, Global Safety Physician, Moderna

Sarah Gilbert, Professor of Vaccinology, University of Oxford

Cynthia Rohde, Drug Safety Research and Development Vaccine Therapeutic Area Lead, Pfizer

Marco Cavaleri, Head of Biological Health Threats and Vaccines Strategy, European Medicines Agency

Kristine Macartney, Director, National Centre for Immunisation Research and Surveillance

Walter Straus, Vice President, Clinical Safety & Risk Management, Moderna Therapeutics

Rebecca Chandler, Clinical Development Vaccine Safety Lead, CEPI

Ofer Levy, Director, Precision Vaccines Program, Boston Children's Hospital